Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIMVASTATIN vs SIRUKUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIMVASTATIN vs SIRUKUMAB: Safety Overview

Metric SIMVASTATIN SIRUKUMAB
Total FAERS Reports 27,079 1,345
Deaths Reported 2,792 847
Death Rate 10.3% 63.0%
Hospitalizations 8,824 812
Average Patient Age 66.6 yrs 43.2 yrs
% Female Patients 47.5% 99.6%
FDA Approval Date Apr 14, 2009 N/A
Manufacturer Aphena Pharma Solutions - Tennessee, LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A